These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16277869)

  • 1. [Immunomodulation of bone marrow mesenchymal stem cells in hematopoietic stem cell transplantation--review].
    Gao L; Wang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):907-10. PubMed ID: 16277869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
    Bernardo ME; Fibbe WE
    Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.
    Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML
    Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
    Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
    Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
    Soleymaninejadian E; Pramanik K; Samadian E
    Am J Reprod Immunol; 2012 Jan; 67(1):1-8. PubMed ID: 21951555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of mesenchymal and hematopoietic stem cells mobilization by G-CSF and its impact on the cytokine microenvironment in primary cultures.
    Garcia NP; de Leon EB; da Costa AG; Tarragô AM; Pimentel JP; Fraporti L; de Araujo FF; Campos FM; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Cell Immunol; 2015 Jan; 293(1):1-9. PubMed ID: 25461611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on immunologic mechanisms of mesenchymal stem cells for treatment of graft-versus-host disease].
    Wang RP; Chen H; Guo YQ; Wu RN; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):550-3. PubMed ID: 21518528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of bone marrow-derived mesenchymal stem cells in reduction of graft-versus-host disease by effecting CD4+CD25+ regulatory T cells in rats].
    Tian Y; Deng YB; Huang YJ; Na XD; Li Y; Ye MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1210-4. PubMed ID: 17204196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells.
    Raicevic G; Najar M; Najimi M; El Taghdouini A; van Grunsven LA; Sokal E; Toungouz M
    Cytotherapy; 2015 Feb; 17(2):174-85. PubMed ID: 25455740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
    Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Cho SJ; Ryu KH
    Cytotherapy; 2010 May; 12(3):361-70. PubMed ID: 20078382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
    De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
    Huang K; Zhou DH; Huang SL; Liang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.
    Wang L; Zhu CY; Ma DX; Gu ZY; Xu CC; Wang FY; Chen JG; Liu CJ; Guan LX; Gao R; Gao Z; Fang S; Zhuo DJ; Liu SF; Gao CJ
    Ann Hematol; 2018 Oct; 97(10):1941-1950. PubMed ID: 29947972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.